Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine

• Murilo S. de Abreu,
• Murilo S. de Abreu,
• Murilo S. de Abreu,
• Ashton J. Friend,
• Ashton J. Friend,
• Tamara G. Amstislavskaya,
• Allan V. Kalueff,
• Allan V. Kalueff,
• Allan V. Kalueff,
• Allan V. Kalueff,
• Allan V. Kalueff,
• Allan V. Kalueff,
• Allan V. Kalueff

Affiliations

Murilo S. de Abreu

Bioscience Institute, University of Passo Fundo, Passo Fundo, Brazil

Murilo S. de Abreu

Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil

Murilo S. de Abreu

Neuroscience Program, School of Science and Engineering, Tulane University, New Orleans, LA, United States

Ashton J. Friend

Neuroscience Program, School of Science and Engineering, Tulane University, New Orleans, LA, United States

Ashton J. Friend

The International Zebrafish Neuroscience Research Consortium, Slidell, LA, United States

Tamara G. Amstislavskaya

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Allan V. Kalueff

School of Pharmacy, Southwest University, Chongqing, China

Allan V. Kalueff

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia

Allan V. Kalueff

Institute of Experimental Medicine, Almazov National Medical Research Center, St. Petersburg, Russia

Allan V. Kalueff

Ural Federal University, Ekaterinburg, Russia

Allan V. Kalueff

0Russian National Granov's Research Center for Radiology and Surgical Technologies, Pesochny, Russia

Allan V. Kalueff

1Laboratory of Translational Biopsychiatry, Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Allan V. Kalueff

2ZENEREI Research Center, Slidell, LA, United States